Backbone assignment of the tyrosine kinase Src catalytic domain in complex with imatinib

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Src tyrosine kinase is a key oncogenic protein and a target for cancer therapy.
• Its regulation involves intramolecular interactions, and it plays roles in cell proliferation and metastasis.
• Understanding Src structure is crucial for developing effective anticancer drugs.

Purpose of the Study:

• To assign protein resonances for the Src kinase catalytic domain in complex with Imatinib.
• To characterize the structural dynamics of Src in the presence of an anticancer drug.
• To provide insights into the mechanism of Src inhibition.

Main Methods:

• Nuclear Magnetic Resonance (NMR) spectroscopy was used to assign protein resonances.
• Resonance assignment included backbone atoms ((1)H(N), (13)C(α), (13)CO, (15)N) and sidechain atoms ((13)C(β)).
• The study focused on the Src catalytic domain (283 residues) complexed with Imatinib.

Main Results:

• Resonance assignments were completed for approximately 88% of the polypeptide backbone.
• Most signals from the Src activation loop were not detected.
• The lack of detected signals suggests heterogeneous conformations in intermediate exchange for the activation loop, even with Imatinib bound.

Conclusions:

• The study successfully assigned a significant portion of the Src catalytic domain resonances in complex with Imatinib.
• The findings indicate that the Src activation loop remains conformationally flexible and disordered in the presence of the drug.
• This structural flexibility may have implications for Src kinase activity and the efficacy of Imatinib as an anticancer agent.